PlainVisa
2026 data Public-data reference Official source

AbbVie Bioresearch Center, Inc.

A DOL Labor Condition Application record spanning FY2023–2026. Review the filing volume, DOL certification record, and offered-wage context below.

DOL LCA filings
85
DOL-certified
100%
Median offered wage
$116,609

Worcestor, MA NAICS: 325412

How many H-1B LCA filings list AbbVie Bioresearch Center, Inc.?

U.S. Department of Labor's OFLC discloses 85 Labor Condition Application filings naming AbbVie Bioresearch Center, Inc. from FY2023 through FY2026, drawn directly from DOL's quarterly public disclosure releases. An LCA is the wage-and-working-conditions attestation an employer files with DOL before petitioning USCIS for an H-1B worker: it is a filing record, not a USCIS approval, a job offer, or a confirmed hire, and the count reflects filings, not people, since an employer sponsoring the same role at more than one worksite, or refiling across fiscal years, is counted once per filing. See filing history · Recent LCAs

How many H-1B petitions has USCIS approved for AbbVie Bioresearch Center, Inc.?

Separate from the DOL filing record above, U.S. Citizenship and Immigration Services adjudicated 57 H-1B petitions naming AbbVie Bioresearch Center, Inc. through FY2024, and approved nearly every one of them: 98.2% approved (56 approvals, 1 denials). A DOL certification is the labor-condition step filed before a petition; this USCIS figure is the actual adjudicated outcome, and the two rates commonly differ.

The verdict

AbbVie Bioresearch Center, Inc. is listed in 85 DOL LCA filings, more filings than 98% of employer filers in this extract. DOL certified 100% of those LCAs; the median listed offered wage is $116,609. This is not a USCIS approval, hiring, or sponsorship ranking.

85
DOL LCA filings, FY2023–FY2026
100%
DOL-certified
$116,609
median offered wage
Top 2%
of employer filers by volume

According to U.S. Department of Labor OFLC LCA disclosure files (FY2023–FY2026). Based in Worcestor, MA.

Saved on this device only, no account, no email. Open saved list Follow this profile's data updates Updates when the published DOL data vintage changes; this is a feed, not an alert service.

AbbVie Bioresearch Center, Inc. vs all U.S. employer filers by LCA volume

Where this employer's disclosed Labor Condition Application count sits among every tracked employer filer (inventory signal, not a sponsorship ranking)

85 3080th of 122824 higher than 119,744 of 122,824 employer filers

Employer filers, banded by disclosed H-1B LCA filing count

Each bar is a band; taller bars hold more employer filers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source U.S. Department of Labor OFLC · FY2023–FY2026

LCA filing shape · AbbVie Bioresearch Center, Inc.

Derived from this employer's disclosed LCAs on file (FY2023–FY2026), title mix and worksite counties, not national boilerplate. LCA filings do not establish USCIS outcomes or confirmed hiring.

Offered-wage span on file: $70,000$201,587 .

Title concentration

  • SENIOR SCIENTIST I 6 · 7.1% · $131,333
  • SENIOR SCIENTIST, CELLULAR/MOLECULAR BIOLOGY II 4 · 4.7% · $148,000
  • SCIENTIST I 4 · 4.7% · $102,750
  • MANAGER, PRODUCT QUALITY 4 · 4.7% · $121,000
  • Senior Scientist II 3 · 3.5% · $140,500

Worksite counties

  • WORCESTER CITY, MA 52 · 74.3%
  • CAMBRIDGE CITY, MA 16 · 22.9%
  • COOK, IL 1 · 1.4%
  • BOSTON CITY, MA 1 · 1.4%

DOL LCA release change

What changed between the two LCA fiscal years

FY2024 -> FY2025
  • AbbVie Bioresearch Center, Inc.'s disclosed H-1B LCA filing count rose from 24 in FY2024 to 32 in FY2025 (+33.3%).
  • AbbVie Bioresearch Center, Inc.'s average disclosed H-1B offered wage rose from $113,535 in FY2024 to $123,740 in FY2025 (+9%).

Arithmetic differences between stored DOL OFLC Labor Condition Application disclosure fiscal years for this employer identity - not a headcount, hire forecast, or cause claim. Role mix can shift between years even when the filing total is flat. Totals group name variants that share the same identity key.

National filing changes Two-year CSV

National-scale filing footprint

AbbVie Bioresearch Center, Inc. has filed 85 LCAs (more volume than 98% of U.S. employer filers in this extract). DOL certification: 100%. Worksites span 2 states , led by MA.

Above-prevailing wage posture

On 85 LCAs with comparable offered vs prevailing wages, AbbVie Bioresearch Center, Inc. averages about 19.6% above the prevailing wage (national baseline ≈ 17.8%). Dominant PW level on file: Qualified (Level II) (37.6% of LCA filings).

Certification Rate

100%

Very high DOL cert

Avg. Salary

$116,609

Near portal avg

Total Workers

85

Moderate worker count

Compare with another employer filer

AbbVie Bioresearch Center, Inc. vs a peer vs the national average, from DOL LCA data.

Avg. offered wage$116,609 · about the same as Fidelity Technology Group, LLC
This filer
Peer
$116,535
National avg.
$113,357
Certification rate100.0% · 1% higher than Fidelity Technology Group, LLC
This filer
Peer
99.4%
National avg.
97.7%
Total LCA filings85 · 98% lower than Fidelity Technology Group, LLC
This filer
Peer
3,809
National avg.
17
FY2025 filings are 136% of FY2023

22 completed-year filings in FY2023, 30 in FY2025. The scale spans up to twice the earlier year's count: the midpoint is unchanged and the endpoint is at least doubled.

Wondering how long it takes USCIS to process an H-1B petition for this employer? See current I-129 processing times →

Salary Analysis

Compensation range for H-1B positions at AbbVie Bioresearch Center, Inc.

Minimum
$70,000
Maximum
$201,587
Average Salary
$116,609

LCA Filing History

H-1B LCA filing trends from FY2023 to FY2026

FY2023 22 LCA filings · 100% DOL-certified · $101,209 avg
FY2024 22 LCA filings · 100% DOL-certified · $115,584 avg
FY2025 30 LCA filings · 100% DOL-certified · $124,508 avg

FY2026 is partial on this extract. Chart shows completed fiscal years only (through FY2025).

Top Occupations

Most frequently listed job titles at AbbVie Bioresearch Center, Inc.

Job Title LCA filings Avg. Salary
SENIOR SCIENTIST I 6 $131,333
SENIOR SCIENTIST, CELLULAR/MOLECULAR BIOLOGY II 4 $148,000
SCIENTIST I 4 $102,750
MANAGER, PRODUCT QUALITY 4 $121,000
Senior Scientist II 3 $140,500
Scientist I 3 $97,021
SENIOR SCIENTIST II 3 $136,000
SENIOR ANALYST, BUSINESS SYSTEMS 2 $123,000
PRINCIPAL RESEARCH SCIENTIST I 2 $152,000
Associate Scientist, Cellular/Molecular Biochemistry II 2 $79,171
ASSOCIATE SCIENTIST II, MULTI-SPECIFIC BIOLOGICS PLATFORM 2 $80,000
Sr. Scientist I - MSAT 1 $131,024
Senior Scientist, Process Development 1 $137,000
Senior Scientist I, Synthetic/Medicinal Chemistry 1 $136,000
Senior Scientist I, Proteomics 1 $139,725

Geographic Distribution

Where AbbVie Bioresearch Center, Inc. places H-1B workers across the United States

MA 84 LCA filings
IL 1 LCA filings

Nationwide peers near AbbVie Bioresearch Center, Inc.'s 85-LCA band

Cross-state DOL neighbors for AbbVie Bioresearch Center, Inc. - LCA filing-count and offered-wage axes, outside MA.

Similar LCA filing volume

Nearest cross-state employer filers by LCA filing count (85 here; floor ≥10 LCA filings).

Similar avg offered wage

Cross-state employer filers with a comparable average listed offered wage ($116,609 here).

Disclaimer: Informational only, not professional advice.

Read with AbbVie Bioresearch Center, Inc.

ABS(total_petitions) peers first, then a LARGEST-distance pole and a stamp-branched drill, not a fixed Related strip. This page stamps MICRO-BOOK · CERT-LOCK · WAGE-PAR.

What to do with this profile

Use the DOL LCA record for AbbVie Bioresearch Center, Inc. to compare filing volume and offered wages, not USCIS outcomes.

DOL disclosure data only. Not legal advice, sponsorship guarantees, or visa eligibility.

Every figure on PlainVisa is rendered directly from federal source data, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error. Data current as of 2026-09-09.